AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Toward Defining the Non-HIV Infectious Diseases Leadership Group

Future Directions for NIAID HIV Research

Co-authored by Carole Heilman, Ph.D., Director of NIAID’s Division of Microbiology and Infectious Diseases Over the course of the past two decades the National Institute of Allergy and Infectious Diseases (NIAID) has developed an extensive set of networks to conduct clinical trials related to HIV/AIDS. These networks have helped to develop effective treatments for AIDS,…

Agency Operational Plans and the President’s FY 2012 Budget Highlight Our Continued Efforts to Implement the National HIV/AIDS Strategy

blog.aids.gov

One of the goals of the National HIV/AIDS Strategy was to refocus existing efforts and deliver better results to the American people within current funding levels, as well as make the case for new investments. The Office of National AIDS Policy (ONAP) is excited to share some of the progress the Obama Administration has made…

Stigma – 30 Years Into the Epidemic

Dr. Anthony Fauci

Our colleague Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID) will appear tonight on "Hope Survives: 30 Years of AIDS," an hour-long special on Anderson Cooper 360° at 9pm ET on CNN. The program will focus on the role stigma continues to play in the spread of HIV, and prevention and…

Which of our Blog Posts and Videos Do YOU View? Looking Back at 2010

Listen:

Javascript and flash are required to play this audio file.

Download MP3
2010

As the AIDS.gov blog's fourth year begins, we at AIDS.gov are taking time to reflect on 2010 and look to the year ahead. As we continue to integrate monitoring and evaluation into our work, we thought that the New Year provided a nice benchmark to look more closely at our blog. For us, the blog…

FDA Approves New Rapid HIV Test Delivering Results in 60 Seconds

Richard Klein

Earlier this week the Food and Drug Administration (FDA) announced the approval of the INSTI™ HIV-1 Antibody Test, a new, single use rapid test for the detection of HIV antibodies developed by bioLytical Laboratories of Canada. The newly approved test provides results in as little as 60 seconds, in contrast to the six previously approved…

World AIDS Day

blog.aids.gov

Every year on December 1, we commemorate World AIDS Day to bring attention to the tremendous impact of the HIV epidemic in the United States and around the world. In observance of World AIDS Day, today CDC launched a special report, CDC Vital Signs on HIV Testing in the United States, in recognition of the…

NIH-Funded Study Finds Daily Dose of Antiretroviral Drug Reduces Risk of HIV

blog.aids.gov

Today, the New England Journal of Medicine published research findings from the iPrEx study funded by the National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation testing the efficacy of pre-exposure prophylaxis (PrEP). The study is a major step forward in our ability to prevent new HIV infections. The study found that…

President Obama Welcomes New HIV Prevention Research Results

blog.aids.gov

WASHINGTON, D.C. – Today, the National Institutes of Health announced findings on recent HIV prevention research.  The study finds that a daily dose of an oral antiretroviral drug taken by HIV-negative gay and bisexual men reduced the risk of acquiring HIV infection by 43.8 percent, and had even higher rates of effectiveness, up to 73…